However, Malaysia University of Science and Technology or MUST professor Dr Geoffrey Williams believes Malaysia will see a long-haul recovery.
Top read stories include AstraZenecca, Pos Malaysia, AIA Malaysia and TNG Digital, Silterra, National Recovery Plan, food delivery platforms
AstraZeneca's Covid-19 shot did not increase the instances of rare blood clots with low platelets in people after the second dose, a study showed on Wednesday, potentially easing some worries over the vaccine's side-effects.
